Clinical trials have indicated that the expression of VEGF-C, VEGF-D or VEGFR-3 is associated with lymph node metastasis and the poor prognosis of patients with cancer [10, 11, 22]. Here, VEGFC is linked to metastatic malignant neoplasm in the lymph nodes.